Steven L. Krill, Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 9,980 shares at $81.60 ($814K) on 2015-06-16, disclosed to the SEC on 2015-06-18.
Open-market sale of $814k EGRX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.60 | 1,400 | $114K | 14.0% |
| 2 | $81.60 | 2,730 | $223K | 27.4% |
| 3 | $81.60 | 5,850 | $477K | 58.6% |
| Total | $81.60 avg | 9,980 | $814K | 100% |
| Filing → |
| EGRX | SELL | 2016-12-15 | $736K | — | Filing → |
| EGRX | SELL | 2016-12-02 | $479K | — | Filing → |